Schizophrenia and viral infection during neurodevelopment: A focus on mechanisms

Molecular Psychiatry

Volumn 6, Issue 6, 2001, Pages 634-646

  Pearce, B D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Blood brain barrier; GABA; Glutamic acid; Hippocampus; Pregnancy complications; Virus diseases

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; NEUROTRANSMITTER;

AUTOIMMUNITY; BEHAVIOR; BLOOD BRAIN BARRIER; DEGENERATIVE DISEASE; GENETIC HETEROGENEITY; HEMISPHERIC DOMINANCE; HEREDITY; HIPPOCAMPUS; HOST SUSCEPTIBILITY; HUMAN; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NERVOUS SYSTEM DEVELOPMENT; NEUROANATOMY; NEUROPSYCHOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; VIRUS PATHOGENESIS;

ANIMALS; BRAIN; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SCHIZOPHRENIA; VIRUS DISEASES;

EID: 0034749995     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000956     Document Type: Review

References (182)

1. Developmental neuropathology and the precursors of schizophrenia
2. Implications of normal brain development for the pathogenesis of schizophrenia
3. Genes, viruses and neurodevelopmental schizophrenia
4. Advancing a neurodevelopmental origin for schizophrenia
5. Minor physical anomalies in alcoholic and schizophrenic adults and hyperactive and autistic children
6. The incidence of minor physical anomalies in adult male schizophrenics
7. Neurodevelopmental abnormalities in schizophrenia: Insights from neuropathology
8. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
9. Schizophrenia and the hippocampus: The embryological hypothesis extended
10. A neurohistological correlate of schizophrenia
11. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains
12. Gliosis in schizophrenia: A survey
13. Monozygotic twins discordant for schizophrenia are discordant for N-CAM and L1 in CSF
14. Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia
15. Schizophrenia: An epigenetic puzzle?
16. Schizophrenia: Genes and environment
17. Familial and genetic mechanisms in schizophrenia
18. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series
19. Are we overestimating the genetic contribution to schizophrenia?
20. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia
21. Placental injection studies in twin gestation
22. Prenatal development of monozygotic twins and concordance for schizophrenia
23. How a poliovirus might cause schizophrenia: A commentary on Eagles' hypothesis
24. On the unpredictable development of congenital cytomegalovirus infection. A study in twins
25. Some causes of genotypic and phenotypic discordance in monozygotic twin pairs
26. Critical overview of current approaches to genetic mechanisms in schizophrenia research
27. The viral hypothesis of schizophrenia
28. Viruses, schizophrenia, and bipolar disorder
29. Retroviruses and schizophrenia revisited
30. Infection and autoimmunity as etiologic factors in schizophrenia: A review and reappraisal
31. Nonaffective psychosis after prenatal exposure to rubella
32. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: A prospective birth cohort study
33. Prenatal influenza infections and adult schizophrenia
34. The relationship of schizophrenic births to 16 infectious diseases
35. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: A 28-year follow-up
36. Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder
37. Association between prenatal exposure to poliovirus infection and adult schizophrenia
38. Isolation of Borna disease virus from human brain tissue
39. Borna disease virus genome transcribed and expressed in psychiatric patients
40. First isolates of infectious human Borna disease virus from patients with mood disorders
41. Clinical similarities and close genetic relationship of human and animal Borna disease virus
42. Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders
43. The neuropathogenesis of Borna disease virus infections
44. At issue: Is household crowding a risk factor for schizophrenia and bipolar disorder?
45. The Nithsdale Schizophrenia Surveys 16. Breast-feeding and schizophrenia: Preliminary results and hypotheses
46. The impact of host genetics on susceptibility to human infectious diseases
47. Is there a viral or immune dysfunction etiology to schizophrenia? Re-evaluation a decade later
48. Diagnosis and classification of schizophrenia
49. Neurohumoural and structural changes in schizophrenia: Two dimensions of pathology
50. Heterogeneity of the psychoses: Is there a neurodegenerative psychosis?
51. Anatomy of schizophrenia revisited
52. The great balancing acts. The pregnant woman, placenta, fetus, and infectious agents
53. Infections in childhood and pregnancy as a cause of adult disease - Methods and examples
54. Age-dependent susceptibility in mumps-associated hydrocephalus: Neuropathologic features and brain barriers
55. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature
56. Problems in the diagnostic laboratory with respect to poliomyelitis
57. Postpolio syndrome: Poliovirus persistence is involved in the pathogenesis
58. Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome
59. The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study
60. Acute axonal Guillain-Barre syndrome with IgG antibodies against motor axons following parenteral gangliosides
61. The Dutch Famine and schizophrenia spectrum disorders
62. On the nature and mechanisms of obstetric influences in schizophrenia: A review and synthesis of epidemiologic studies
63. Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrodes
64. Neonatal nosocomial infections
65. An analysis of lymphocyte subpopulations in schizophrenic patients
66. Elevation of CD5+ B lymphocytes in schizophrenia
67. Increased numbers of CD5+ B lymphocytes in schizophrenic patients
68. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset
69. Autoimmunity in schizophrenia: A review of recent findings
70. Increased prevalence of antibrain antibodies in the sera from schizophrenic patients
71. An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia
72. Molecular mimicry and immune-mediated diseases
73. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS
74. Update on the role of the blood-brain barrier in damage to immature brain
75. Blood-cerebrospinal fluid barrier in schizophrenic patients
76. Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia
77. Autoimmune diseases of the central and peripheral nervous systems
78. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
79. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma
80. Schizophrenia: Genetics and the maternal immune response to viral infection
81. HLA-DR (Ia)-positive dendritic-like cells in human fetal nonlymphoid tissues
82. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, and DO) in human fetal adrenal, pancreas, thyroid, and gut
83. Cytokine and growth factor involvement in schizophrenia - Support for the developmental model
84. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain
85. Pathobiology of human immunodeficiency virus dementia
86. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome
87. The neuropathology of schizophrenia. A critical review of the data and their interpretation
88. Recent advances in the neuropathology of schizophrenia
89. Emerging principles of altered neural circuitry in schizophrenia
90. The mechanism of neuronal damage in virus infections of the nervous system
91. Pathogenesis of viral infections
92. Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus?
93. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice
94. Disordered migration and loss of virus-infected neuronal cells in developing mouse brains infected with murine cytomegalovirus
95. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain
96. Parvovirus minute virus of mice strain i multiplication and pathogenesis in the newborn mouse brain are restricted to proliferative areas and to migratory cerebellar young neurons
97. A decrease of reelin expression as a putative vulnerability factor in schizophrenia
98. Neurotransmitter systems in schizophrenia
99. An integrated view of pathophysiological models of schizophrenia
100. Virus infections in infant mice causing persistent impairment of turnover of brain catecholamines
101. Behavioral consequences of virus infections
102. Viruses and behavioural changes: A review of clinical and experimental findings
103. Learning deficiencies in Borna disease virus-infected but clinically healthy rats
104. Effects of neonatal rat Borna disease virus (BDV) infection on the postnatal development of the brain monoaminergic systems
105. Prefrontal cortex dysfunction in Borna disease virus (BDV)-infected rats
106. The current status of the dopamine hypothesis of schizophrenia
107. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
108. Reduced GABA uptake sites in the temporal lobe in schizophrenia
109. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia
110. Evidence of glutamatergic deficiency in schizophrenia
111. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
112. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients
113. Free amino acid level determinations in normal and schizophrenic brain
114. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
115. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
116. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia
117. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics
118. Neuropeptide deficits in schizophrenia vs Alzheimer's disease cerebral cortex
119. Postmortem studies in schizophrenia
120. Peptides, the limbic lobe and schizophrenia
121. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia
122. Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia
123. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains
124. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
125. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia
126. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
127. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain
128. What is the role of glutamate in schizophrenia?
129. Glutamate receptor expression in schizophrenic brain
130. Development, disease and degeneration in schizophrenia: A unitary pathophysiological model
131. The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease
132. Laterality in animals: Relevance to schizophrenia
133. Functional neuropsychophysiological asymmetry in schizophrenia: A review and reorientation
134. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease
135. Hippocampal pathologic findings in schizophrenia. A morphometric study
136. The hippocampus in schizophrenia: Lateralized increase in neuronal density and altered cytoarchitectural asymmetry
137. Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder
138. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia
139. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia
140. Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: Relationship to symptom specificity
141. Brain lateralization and immunomodulation
142. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia
143. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
144. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism
145. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients
146. Brain morphology in first-episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study
147. Childhood-onset schizophrenia. Progressive ventricular change during adolescence
148. Progressive ventricular enlargement in schizophrenia: Comparison to bipolar affective disorder and correlation with clinical course
149. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective
150. To model a psychiatric disorder in animals: Schizophrenia as a reality test
151. Investigations of fetal development models for prenatal drug exposure and schizophrenia. Prenatal d-amphetamine effects upon early and late juvenile behavior in the rat
152. Sensory gating in rats depleted of dopamine as neonates: Potential relevance to findings in schizophrenic patients
153. Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders
154. Use of toxins to disrupt neurotransmitter circuitry in the developing brain
155. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage
156. Neurodevelopmental animal models of schizophrenia
157. On the effect of neonatal nitric oxide synthase inhibition in rats: A potential neurodevelopmental model of schizophrenia
158. Effects of perinatal anoxia on the acute locomotor response to repeated amphetamine administration in adult rats
159. Prenatal malnutrition and development of the brain
160. Neonatal insult to the hippocampal region and schizophrenia: A review and a putative animal model
161. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia
162. Neonatal herpes simplex virus type 1 brain infection affects the development of sensorimotor gating in rats
163. Host genetics and the behavioral sequelae to herpes encephalitis in mice
164. Virus-induced behavioral alteration of mice
165. Neurobiology of LCM virus infection in rodents
166. Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells
167. Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: A model of autism
168. An infection-based model of neurodevelopmental damage
169. The development of the human hippocampal fissure
170. Persistent dentate granule cell hyperexcitability after neonatal infection with lymphocytic choriomeningitis virus
171. Viral infection of developing GABAergic neurons in a model of hippocampal disinhibition
172. Pathogenesis of LCMV disease in the rat
173. Mosaic organization of the hippocampal neuroepithelium and the multiple germinal sources of dentate granule cells
174. Teratogenic effects of neonatal arenavirus infection on the developing rat cerebellum are abrogated by passive immunotherapy
175. Evidence for changing positions of GABA neurons in the developing rat dentate gyrus
176. Area-specific morphological and neurochemical maturation of non-pyramidal neurons in the rat hippocampus as revealed by parvalbumin immunocytochemistry
177. Lymphocytic responses and the gradual hippocampal neuron loss following infection with lymphocytic choriomeningitis virus (LCMV)
178. Anatomy of viral persistence: Mechanisms of persistence and associated disease
179. Delay in treating schizophrenia may narrow therapeutic window of opportunity
180. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain